Print this page    •   Back to Web version of article

Bottom Line on the Three New Drugs

October 2003

Enfuvirtide (T-20, Fuzeon)


Atazanavir (Reyataz)


Emtricitabine (FTC, Emtriva)


Back to the Project Inform Perspective October 2003 contents page.




This article was provided by Project Inform. It is a part of the publication Project Inform Perspective. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art5498.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.